Junji Takada

838 total citations
20 papers, 709 citations indexed

About

Junji Takada is a scholar working on Molecular Biology, Pharmacology and Organic Chemistry. According to data from OpenAlex, Junji Takada has authored 20 papers receiving a total of 709 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Pharmacology and 6 papers in Organic Chemistry. Recurrent topics in Junji Takada's work include Inflammatory mediators and NSAID effects (8 papers), Nitric Oxide and Endothelin Effects (5 papers) and ATP Synthase and ATPases Research (4 papers). Junji Takada is often cited by papers focused on Inflammatory mediators and NSAID effects (8 papers), Nitric Oxide and Endothelin Effects (5 papers) and ATP Synthase and ATPases Research (4 papers). Junji Takada collaborates with scholars based in Japan, United States and United Kingdom. Junji Takada's co-authors include Akio Murase, Mitsuo Yano, Kenji Matsuyama, Kenji Okada, Clifford J. Woolf, Chung‐Ren Lin, Haibin Wang, Tarek A. Samad, Fumimasa Amaya and Lee Barrett and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Journal of Pharmacology and Experimental Therapeutics and Biochimica et Biophysica Acta (BBA) - Biomembranes.

In The Last Decade

Junji Takada

20 papers receiving 666 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Junji Takada Japan 12 330 242 190 114 106 20 709
Michael A. Trevethick United Kingdom 19 359 1.1× 377 1.6× 376 2.0× 76 0.7× 242 2.3× 36 1.2k
B S Tsai United States 19 377 1.1× 186 0.8× 565 3.0× 92 0.8× 345 3.3× 37 1.1k
Phillip J. Gardiner United Kingdom 19 873 2.6× 418 1.7× 365 1.9× 42 0.4× 226 2.1× 40 1.3k
V A Alabaster United Kingdom 15 172 0.5× 106 0.4× 379 2.0× 80 0.7× 197 1.9× 24 749
Ralph E. Giles United States 15 370 1.1× 121 0.5× 166 0.9× 29 0.3× 91 0.9× 33 705
C. Rochette Canada 10 227 0.7× 623 2.6× 362 1.9× 72 0.6× 204 1.9× 12 1.1k
尚三 山本 3 137 0.4× 151 0.6× 143 0.8× 46 0.4× 38 0.4× 3 555
Hideji Karibe Japan 13 148 0.4× 168 0.7× 273 1.4× 146 1.3× 38 0.4× 25 684
Frank Neuschäfer‐Rube Germany 15 145 0.4× 284 1.2× 303 1.6× 30 0.3× 105 1.0× 25 717
Beavo Ja United States 7 178 0.5× 101 0.4× 492 2.6× 110 1.0× 189 1.8× 7 776

Countries citing papers authored by Junji Takada

Since Specialization
Citations

This map shows the geographic impact of Junji Takada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junji Takada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junji Takada more than expected).

Fields of papers citing papers by Junji Takada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junji Takada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junji Takada. The network helps show where Junji Takada may publish in the future.

Co-authorship network of co-authors of Junji Takada

This figure shows the co-authorship network connecting the top 25 collaborators of Junji Takada. A scholar is included among the top collaborators of Junji Takada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junji Takada. Junji Takada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Murase, Akio, et al.. (2014). Design, synthesis and structure–activity relationship studies of novel and diverse cyclooxygenase-2 inhibitors as anti-inflammatory drugs. Journal of Enzyme Inhibition and Medicinal Chemistry. 29(6). 846–867. 7 indexed citations
2.
Murase, Akio, et al.. (2012). Novel acid-type cyclooxygenase-2 inhibitors: Design, synthesis, and structure–activity relationship for anti-inflammatory drug. European Journal of Medicinal Chemistry. 50. 179–195. 39 indexed citations
3.
Takada, Junji, et al.. (2011). Growth and Photosynthesis of Ulva prolifera under Different Light Quality from Light Emitting Diodes (LEDs). Aquaculture Science. 59(1). 101–107. 5 indexed citations
4.
5.
Murase, Akio, Kazunari Nakao, & Junji Takada. (2008). Characterization of Binding Affinity of CJ-023,423 for Human Prostanoid EP<sub>4</sub> Receptor. Pharmacology. 82(1). 10–14. 3 indexed citations
6.
Murase, Akio, et al.. (2007). Effect of prostanoid EP4 receptor antagonist, CJ-042,794, in rat models of pain and inflammation. European Journal of Pharmacology. 580(1-2). 116–121. 48 indexed citations
7.
Murase, Akio, Yasuhito Taniguchi, Hiroko Tonai‐Kachi, Kazunari Nakao, & Junji Takada. (2007). In vitro pharmacological characterization of CJ-042794, a novel, potent, and selective prostaglandin EP4 receptor antagonist. Life Sciences. 82(3-4). 226–232. 41 indexed citations
8.
Nakao, Kazunari, Akio Murase, Hiroyuki Ohshiro, et al.. (2007). CJ-023,423, a Novel, Potent and Selective Prostaglandin EP4 Receptor Antagonist with Antihyperalgesic Properties. Journal of Pharmacology and Experimental Therapeutics. 322(2). 686–694. 99 indexed citations
9.
Lin, Chung‐Ren, Fumimasa Amaya, Lee Barrett, et al.. (2006). Prostaglandin E2 Receptor EP4 Contributes to Inflammatory Pain Hypersensitivity. Journal of Pharmacology and Experimental Therapeutics. 319(3). 1096–1103. 205 indexed citations
10.
Nagamune, Hideaki, Yoshihiro Fukushima, Junji Takada, et al.. (1993). The lipophilic weak base (Z)-5-methyl-2-[2-(1-naphthyl)ethenyl]-4-piperidinopyridine (AU-1421) is a potent protonophore type cationic uncoupler of oxidative phosphorylation in mitochondria. Biochimica et Biophysica Acta (BBA) - Bioenergetics. 1141(2-3). 231–237. 20 indexed citations
11.
Takada, Junji, M. Hata, Kenji Okada, Kenji Matsuyama, & Mitsuo Yano. (1992). Biochemical properties of endothelin converting enzyme in renal epithelial cell lines. Biochemical and Biophysical Research Communications. 182(3). 1383–1388. 15 indexed citations
12.
Fukushima, Yoshihiro, Shinji Asano, & Junji Takada. (1992). K+-site-directed pyridine derivative, AU-1421, activates hydrolysis of the K+-sensitive phosphoenzyme of sarcoplasmic reticulum Ca2+-ATPase and inactivates that of K+-transporting ATPases. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1106(1). 71–76. 1 indexed citations
13.
Takada, Junji, et al.. (1991). Phosphoramidon-sensitive endothelin-converting enzyme in the cytosol of cultured bovine endothelial cells. Biochemical and Biophysical Research Communications. 176(2). 860–865. 36 indexed citations
14.
Okada, Kenji, et al.. (1991). Importance of the C-terminal region of big endothelin-1 for specific conversion by phosphoramidon-sensitive endothelin converting enzyme. Biochemical and Biophysical Research Communications. 180(2). 1019–1023. 22 indexed citations
15.
Yano, Mitsuo, Kenji Okada, Junji Takada, et al.. (1991). Endothelin-Converting Enzyme and Its in vitro and in vivo Inhibition. Journal of Cardiovascular Pharmacology. 17. S26–28. 15 indexed citations
16.
Takada, Junji, et al.. (1991). Environmental differences of a pyridine derivative (AU-1421)-access sites between (H+,K+)-ATPase and (Na+,K+)-ATPase.. Journal of Pharmacobio-Dynamics. 14(3). 170–175. 1 indexed citations
17.
Takada, Junji, et al.. (1990). (Z)-5-Methyl-2-[2-(1-naphthyl)ethenyl]-4-piperidinopyridine (AU-1421), calcium ions and ethylenediamine as the K+-site directed probe for Na+/K+-ATPase. Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology. 1041(2). 123–128. 2 indexed citations
18.
Okada, Kenji, et al.. (1990). Conversion of big endothelin-1 by membrane-bound matalloendopeptidase in cultured bovine endothelial cells. Biochemical and Biophysical Research Communications. 171(3). 1192–1198. 121 indexed citations
19.
Takada, Junji, et al.. (1990). A newly synthesized pyridine derivative, (Z)-5-methyl-2-[2-(1-naphthyl)ethenyl]-4-piperidinopyridine hydrochloride (AU-1421), as a reversible gastric proton pump inhibitor.. PubMed. 305. 32–44. 5 indexed citations
20.
Takeshita, Hiroshi, et al.. (1990). Antisecretory properties of a new reversible proton pump inhibitor, AU-2064. The Japanese Journal of Pharmacology. 52. 242–242. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael A. Trevethick Breakdown of academic impact, for papers by B S Tsai Breakdown of academic impact, for papers by Phillip J. Gardiner Breakdown of academic impact, for papers by V A Alabaster Breakdown of academic impact, for papers by Ralph E. Giles Breakdown of academic impact, for papers by C. Rochette Breakdown of academic impact, for papers by 尚三 山本 Breakdown of academic impact, for papers by Hideji Karibe Breakdown of academic impact, for papers by Frank Neuschäfer‐Rube Breakdown of academic impact, for papers by Beavo Ja
Rankless by CCL
2026